Chiropractic Rehabilitation for Better Health from Migraines

Discover effective techniques in chiropractic rehabilitation for migraines for addressing headache issues and restoring balance.

Abstract

Migraine is a complex, primary neurological disorder that affects more than one billion people worldwide and ranks among the leading causes of disability. It is not simply a bad headache. It is a disorder of sensory processing and brain-network dysregulation that produces recurrent attacks lasting hours to days, accompanied by a wide range of neurological, autonomic, and musculoskeletal symptoms. In this educational guide, I, Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, present the latest evidence-based understanding of migraine physiology, the full spectrum of symptoms, the profound effects on daily life, and the practical ways integrative chiropractic care and other non-surgical approaches can be combined with medical care. I explain the clinical guidelines for onabotulinumtoxinA (Botox) in chronic migraine, evidence-informed home strategies, and how our multidisciplinary team at Injury Medical Clinic PA (also known as Mission Plaza Injury Medical Clinic) in El Paso, Texas, coordinates care. Dr. Maria Guadalupe Cardenas, MD (Board Certified in Internal Medicine, NPI #1164426749, Texas MD License #J2933), has more than 40 years of experience as an internist and serves as Medical Director and Collaborative Physician. This structure allows medical oversight, functional-medicine assessment, chiropractic treatment, rehabilitation, and personal-injury care to work together. The purpose is to give readers a clear, sequential understanding of why migraine occurs, why certain treatments are used, and how a coordinated plan can raise the threshold for attacks and restore function.

Understanding Migraine as a Brain Network Disorder

Migraine arises from a genetically influenced, environmentally modulated hyperexcitability of the central nervous system. The core process involves the trigeminovascular system—the network of trigeminal sensory neurons that innervate the meninges, large intracranial vessels, and extracranial structures. When these neurons are activated, they release neuropeptides, most importantly calcitonin gene-related peptide (CGRP) and substance P. CGRP produces potent vasodilation and neurogenic inflammation and sensitizes both peripheral nociceptors and second-order neurons in the trigeminocervical complex. This sensitization explains why ordinary light, sound, smell, or neck movement can become intensely painful during an attack.

Cortical spreading depression is the electrophysiological event that underlies migraine aura. A wave of neuronal and glial depolarization spreads across the cortex at 2–6 mm per minute, followed by a period of suppressed activity. This wave can activate meningeal nociceptors and thereby trigger the headache phase even in patients who do not experience clinical aura. The hypothalamus is active hours before pain begins; functional imaging shows hypothalamic activation during the prodrome, linking premonitory symptoms such as yawning, fatigue, and food cravings to attack initiation. Brainstem nuclei, including the periaqueductal gray and locus coeruleus, modulate descending pain inhibition and can become dysfunctional, allowing pain signals to amplify. Thalamocortical dysrhythmia further contributes to sensory hypersensitivity.

These mechanisms are not static. Repeated attacks produce central sensitization: the threshold for activating pain pathways falls, so milder stimuli can trigger attacks and the pain spreads beyond its original location. The majority of migraine patients report neck pain, and it is not merely a secondary symptom; nociceptive input from upper cervical segments converges with trigeminal input in the trigeminocervical complex, creating a bidirectional relationship. Mechanical strain in the cervical spine or pericranial muscles can lower the threshold for an attack, while an active migraine can increase cervical muscle tension and joint stiffness. This interdependence is why an integrative approach that addresses both the central neurological drivers and the peripheral musculoskeletal contributors is clinically useful.

The Phases and Symptoms of a Migraine Attack

A complete migraine attack is usually divided into four phases, although not every patient experiences all of them and the boundaries can blur.

The prodrome, or premonitory phase, can begin 24–48 hours before head pain. Common symptoms include fatigue, yawning, neck stiffness, difficulty concentrating, mood changes, increased urination, and specific food cravings. These symptoms reflect hypothalamic and brainstem activity and give patients a window for early behavioral interventions (hydration, rest, gentle movement, or medication when appropriate) that may reduce attack intensity.

Aura occurs in approximately one-third of people with migraine and typically lasts 5–60 minutes. Visual aura is most common and may include scintillating scotoma, zigzag lines, or temporary visual loss. Sensory aura produces tingling or numbness that spreads over the face or hand. Language or motor aura is less frequent. Aura is caused by cortical spreading depression and is followed, in most cases, by the headache phase.

The headache phase itself is characterized by moderate-to-severe pain that is often unilateral, pulsating, and aggravated by routine physical activity. Associated features include nausea, vomiting, photophobia, phonophobia, and osmophobia. Many patients also report cranial autonomic symptoms (tearing, nasal congestion) or cutaneous allodynia—pain from normally non-painful touch of the scalp or face. Allodynia is a clinical marker of central sensitization and predicts a higher likelihood of progression to chronic migraine if not controlled.

The postdrome, or “migraine hangover,” can last 24–48 hours after the pain resolves. Patients commonly describe fatigue, difficulty concentrating, neck stiffness, and mood changes. This phase is driven by the same network changes that initiated the attack, along with the metabolic and inflammatory consequences of prolonged neuronal activation.

In clinical practice, I see that patients often under-report the full symptom complex because they have been told for years that migraine is “just a headache.” When we systematically ask about prodrome, aura, allodynia, and postdrome, the picture becomes clearer, and we can better match treatment to the mechanism.

How Migraine Affects Day-to-Day Life

The burden of migraine extends far beyond the hours of head pain. During an attack, most people cannot work, drive, or care for children. Even between attacks, anticipatory anxiety and the need to avoid triggers can restrict social activities, travel, and exercise. Sleep is frequently disrupted both by nocturnal attacks and by the fear of waking with a migraine. Over time, many patients develop kinesiophobia—fear of movement—because physical activity has reliably triggered or worsened attacks in the past. This leads to deconditioning, increased neck and shoulder tension, and a further lowered attack threshold.

Chronic migraine (≥15 headache days per month for more than three months, with at least eight migraine days) produces especially high disability. Patients may spend more days of the month in some degree of pain than free of pain. Work productivity declines, relationships are strained, and the risk of medication-overuse headache rises when acute medications are used on 10 or more days per month. Depression and anxiety are common comorbidities; the relationship is bidirectional—migraine increases the risk of mood disorders, and mood disorders increase migraine frequency and severity.

Musculoskeletal consequences are equally important. Prolonged protective posturing, reduced cervical mobility, and myofascial trigger points in the suboccipital, upper trapezius, and levator scapulae muscles become self-perpetuating sources of nociception that feed into the trigeminocervical complex. In personal-injury and occupational settings, I frequently evaluate patients whose migraine pattern worsened after a motor-vehicle collision or cumulative strain; the original neurological disorder and the new mechanical injury interact, making integrated care essential.

Migraine Pain Treatment El Paso, TX Chiropractor- Video

Why Integrative Chiropractic Care and Non-Surgical Treatments Are Used

Chiropractic care does not cure the central neurological disorder of migraine, and evidence does not support spinal manipulation as a stand-alone treatment. It is used because a substantial subset of patients have coexisting cervical segmental dysfunction, myofascial pain, and altered proprioceptive input that lower the threshold for attacks and amplify pain during attacks. Precise, low-force or instrument-assisted adjustments can restore segmental motion, reduce nociceptive afferent traffic into the trigeminocervical complex, and improve the patient’s ability to tolerate exercise and postural retraining. Soft-tissue techniques address trigger points that refer pain into the head and that maintain protective muscle guarding. Postural and scapular stabilization exercises improve the neck’s mechanical environment so daily activities produce less cumulative strain.

The reasoning is mechanistic and practical. Reducing peripheral nociceptive drive can raise the threshold for central sensitization. Improving sleep architecture by decreasing nighttime neck pain supports the natural recovery processes that occur during slow-wave sleep. Enabling regular aerobic exercise is valuable because multiple studies show that regular moderate aerobic activity reduces migraine frequency; many patients cannot begin or sustain such exercise until cervical and myofascial pain decrease. These effects are adjunctive: they support, rather than replace, evidence-based acute and preventive pharmacotherapy.

Other non-surgical modalities are selected for complementary reasons. Physical therapy provides graded exposure to movement and progressive strengthening once acute irritability has decreased. Massage therapy or myofascial release can temporarily reduce pericranial tenderness and improve comfort between chiropractic visits. Functional-medicine strategies target modifiable amplifiers—sleep regularity, magnesium status, consistent meal timing, hydration, and identification of individual dietary or environmental triggers—because these factors influence neuronal excitability and inflammatory tone. Acupuncture has moderate evidence for preventive benefit in some patients and can be coordinated when appropriate. The common principle is to match the intervention to the dominant pain mechanism (nociceptive, neuropathic, or nociplastic) while maintaining medical oversight for the primary neurological disorder.

Botox for Chronic Migraine: Mechanism, Guidelines, and Clinical Integration

OnabotulinumtoxinA (Botox) is FDA-approved for the prevention of headaches in adults with chronic migraine. It is not indicated for episodic migraine and is not an abortive treatment for an acute attack. The PREEMPT injection paradigm, established in the Phase III Research Evaluating Migraine Prophylaxis Therapy trials, uses 155 units across 31 injection sites in seven head-and-neck muscle groups, repeated every 12 weeks. The toxin cleaves SNAP-25, a protein required for vesicular fusion, thereby inhibiting the release of CGRP, substance P, and other transmitters from peripheral sensory terminals. This reduces both peripheral sensitization and the secondary central sensitization that maintains chronic migraine.

Clinical guidelines and typical payer criteria require a diagnosis of chronic migraine and, in most cases, inadequate response to at least two other preventive medication classes before coverage is approved. Providers usually assess benefit after two or three treatment cycles because the reduction in headache days accumulates. Approximately half of responders experience a 50 percent or greater reduction in headache days. The most common side effect is transient neck soreness, which you can manage with ice and gentle mobility work.

In our clinic, we determine candidacy collaboratively. Dr. Cardenas provides internal medicine oversight for medical comorbidities, medication interactions, and overall preventive strategy. I evaluate coexisting cervical and myofascial findings that may influence comfort and response. Pre- and post-injection soft-tissue treatment and cervical mobility work reduce local soreness and address the mechanical factors that continue to feed into the trigeminocervical complex between injection cycles. Botox is therefore one component of a broader plan, not an isolated intervention.

Evidence-Informed Home Strategies and Why They Work

Home strategies are used because they directly influence the same physiological systems that drive attacks—neuronal excitability, sleep architecture, autonomic balance, and inflammatory tone.

Consistent sleep and wake times stabilize circadian and hypothalamic rhythms that are disrupted in migraine. Aiming for 7–9 hours and protecting the final hours of sleep reduces the likelihood of sleep-deprivation-triggered attacks. Hydration and regular meals prevent the drops in blood glucose and the increases in stress hormones that can activate the trigeminovascular system. A simple headache diary that records sleep, meals, stress, weather, and menstrual cycle (when relevant) allows patients and clinicians to identify personal triggers with greater precision than memory alone.

Moderate aerobic exercise, once cervical irritability is controlled, raises the attack threshold through multiple mechanisms: improved endothelial function, reduced systemic inflammation, better sleep, and enhanced descending pain inhibition. Diaphragmatic breathing and brief relaxation practices lower sympathetic tone and can be used both preventively and at the first sign of prodrome. Magnesium supplementation (typically 400–600 mg elemental magnesium daily in a well-absorbed form) is supported by modest evidence and is mechanistically plausible because magnesium modulates NMDA-receptor activity and vascular tone; use it only after confirming there are no contraindications. Caffeine and alcohol are managed rather than universally eliminated: sudden withdrawal or excess can both trigger attacks, so consistency is the practical goal.

These measures are not substitutes for medical care. They are daily behaviors that make pharmacological prevention and procedural interventions more effective and reduce the disorder’s overall burden.

Integrating Care at Injury Medical Clinic PA

At Injury Medical Clinic PA in El Paso, the model is deliberately multidisciplinary. Dr. Maria Guadalupe Cardenas, MD, Board Certified in Internal Medicine, serves as Medical Director and Collaborative Physician. With more than 40 years of experience, she provides medical direction for complex internal medicine issues, coordinates diagnostic evaluation when secondary headache causes must be excluded, and collaborates on selecting and monitoring preventive medications, including Botox when criteria are met. I, Dr. Alexander Jimenez, bring dual credentials as a chiropractor and board-certified Family Nurse Practitioner, together with functional-medicine and cranial-spinal training. This allows simultaneous assessment of neuromusculoskeletal findings, autonomic contributors, nutritional status, and the medical aspects of migraine within a single clinical relationship, while still respecting the distinct roles of the collaborative physician.

Rehabilitation therapists address progressive strengthening and graded activity. Functional-medicine protocols target sleep, nutrition, and metabolic amplifiers. When personal-injury or occupational factors are present, the same team documents the interaction between the pre-existing migraine disorder and the new mechanical injury so that care remains coordinated. The reasoning behind this structure is straightforward: migraine is a neurological disorder that is powerfully influenced by sleep, neck mechanics, metabolic health, and stress physiology. No single discipline addresses all of these domains. By keeping medical oversight, chiropractic care, rehabilitation, and lifestyle intervention inside one coordinated plan, we reduce fragmentation and give patients a clearer path from acute attack management to long-term reduction in frequency and severity.

Building a Sustainable Health and Wellness Routine

A practical routine begins with accurate diagnosis and baseline measurement (headache days, migraine days, acute-medication days, and disability scores). Optimize acute treatment so attacks are aborted early and medication-overuse headache is avoided. Preventive therapy—whether pharmacologic, Botox, or both—is selected based on guidelines and patient-specific factors and reassessed at defined intervals. Concurrently, cervical mobility, myofascial pain, and postural endurance are addressed so that daily activities and exercise become tolerable. Sleep regularity, hydration, meal timing, and identified triggers are managed as non-negotiable foundations. Periodic re-evaluation ensures that the plan evolves as the patient’s threshold rises and as life circumstances change.

Patients who follow this integrated path commonly report fewer headache days, shorter attacks when they occur, improved sleep, greater exercise tolerance, and reduced fear of the next attack. These outcomes are not guaranteed for every individual. Still, they are the predictable result of simultaneously lowering peripheral nociceptive drive, stabilizing the physiological systems that influence neuronal excitability, and using evidence-based medical prevention for the central disorder itself.

References

• American Migraine Foundation. (n.d.). Botox for migraine.
• Ashina, M., Katsarava, Z., Do, T. P., Buse, D. C., Pozo-Rosich, P., Özge, A., Krymchantowski, A. V., Lebedeva, E. R., Ravishankar, K., Yu, S., Sacco, S., Ashina, S., Younis, S., Steiner, T. J., & Lipton, R. B. (2021). Migraine: Epidemiology and systems of care. The Lancet, 397(10283), 1485–1495.
• Dodick, D. W., Turkel, C. C., DeGryse, R. E., Aurora, S. K., Silberstein, S. D., Lipton, R. B., Diener, H. C., & Brin, M. F. (2010). OnabotulinumtoxinA for treatment of chronic migraine: Pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache, 50(6), 921–936.
• Goadsby, P. J., Holland, P. R., Martins-Oliveira, M., Hoffmann, J., Schankin, C., & Akerman, S. (2017). Pathophysiology of migraine: A disorder of sensory processing. Physiological Reviews, 97(2), 553–622.
• Jimenez, A. (2026). Clinical educational materials on integrative migraine care. Retrieved from dralexjimenez.com and chiromed.com.
• Silberstein, S. D., Holland, S., Freitag, F., Dodick, D. W., Argoff, C., & Ashman, E. (2012). Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults. Neurology, 78(17), 1337–1345.

SEO tags: migraine guide, chiropractic care for migraines, Botox chronic migraine PREEMPT, integrative migraine treatment El Paso, non-surgical migraine management, trigeminovascular system CGRP, Dr Alexander Jimenez migraine, Injury Medical Clinic PA, Dr Maria Guadalupe Cardenas, home strategies migraine prevention, cervical dysfunction and migraine, chronic migraine wellness routine